Vectors Research Management, LLC Abb Vie Inc. Transaction History

Vectors Research Management, LLC

$330 Million
Q3 2024

A detailed history of Vectors Research Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Vectors Research Management, LLC holds 1,411 shares of ABBV stock, worth $247,461. This represents 0.08% of its overall portfolio holdings.

Number of Shares

1,411

Previous 1,411 -0.0%

Holding current value

$247,461

Previous $242,000 15.29%

% of portfolio

0.08%

Previous 0.07%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$159.82 - $182.1 $40,754 - $46,435	-255 Reduced 15.31%	1,411 $257,000
Q3 2023 Nov 09, 2023	SELL	$133.59 - $154.65 $48,493 - $56,137	-363 Reduced 17.89%	1,666 $241,000
Q2 2023 Aug 08, 2023	SELL	$132.51 - $164.9 $13,251 - $16,490	-100 Reduced 4.7%	2,029 $273,000
Q1 2023 May 04, 2023	SELL	$144.61 - $166.54 $12,291 - $14,155	-85 Reduced 3.84%	2,129 $339,000
Q3 2022 Nov 08, 2022	SELL	$134.21 - $153.93 $18,789 - $21,550	-140 Reduced 5.95%	2,214 $297,000
Q1 2022 May 16, 2022	SELL	$131.98 - $163.75 $9,898 - $12,281	-75 Reduced 3.09%	2,354 $382,000
Q4 2021 Feb 15, 2022	BUY	$107.43 - $135.93 $16,221 - $20,525	151 Added 6.63%	2,429 $329,000
Q3 2021 Nov 12, 2021	SELL	$106.4 - $120.78 $10,640 - $12,078	-100 Reduced 4.21%	2,278 $246,000
Q1 2021 May 18, 2021	SELL	$102.3 - $112.62 $13,708 - $15,091	-134 Reduced 5.33%	2,378 $257,000
Q4 2020 Feb 09, 2021	SELL	$80.49 - $108.67 $14,407 - $19,451	-179 Reduced 6.65%	2,512 $269,000
Q3 2020 Nov 16, 2020	BUY	$85.91 - $100.83 $10,738 - $12,603	125 Added 4.87%	2,691 $225,000
Q1 2020 May 14, 2020	SELL	$64.5 - $97.79 $27,928 - $42,343	-433 Reduced 14.44%	2,566 $196,000
Q4 2019 Feb 14, 2020	BUY	$72.13 - $90.25 $54,458 - $68,138	755 Added 33.65%	2,999 $266,000
Q2 2019 Aug 12, 2019	SELL	$65.7 - $83.98 $22,995 - $29,393	-350 Reduced 13.49%	2,244 $163,000
Q1 2019 Jul 15, 2019	BUY	$77.14 - $90.79 $23,142 - $27,237	300 Added 13.08%	2,594 $209,000
Q4 2018 Feb 13, 2019	BUY	$77.85 - $96.01 $3,892 - $4,800	50 Added 2.23%	2,294 $211,000
Q3 2018 Nov 15, 2018	BUY	$88.91 - $98.84 $199,514 - $221,796	2,244 New	2,244 $209,000

Others Institutions Holding ABBV

# of Institutions

3,852

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vectors Research Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vectors Research Management, LLC with notifications on news.

Account

Vectors Research Management, LLC Abb Vie Inc. Transaction History